(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrazin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrazin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrimidin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrimidin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid

C84H80F4N20O16 — CID 161300539

IUPAC(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrazin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrazin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrimidin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrimidin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
SMILESC[C@H]1COc2c(N3CCN(c4cnccn4)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(c4ncccn4)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CC[C@@H](Nc4cnccn4)C3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CC[C@@H](Nc4ncccn4)C3)c(F)cc3c(=O)c(C(=O)O)cn1c23
InChIInChI=1S/4C21H20FN5O4/c1-11-10-31-20-17-13(19(28)14(21(29)30)9-27(11)17)6-15(22)18(20)26-5-2-12(8-26)25-16-7-23-3-4-24-16;1-11-10-31-19-16-13(18(28)14(20(29)30)9-27(11)16)7-15(22)17(19)26-6-3-12(8-26)25-21-23-4-2-5-24-21;1-12-11-31-20-17-13(19(28)14(21(29)30)10-27(12)17)8-15(22)18(20)26-6-4-25(5-7-26)16-9-23-2-3-24-16;1-12-11-31-19-16-13(18(28)14(20(29)30)10-27(12)16)9-15(22)17(19)25-5-7-26(8-6-25)21-23-3-2-4-24-21/h3-4,6-7,9,11-12H,2,5,8,10H2,1H3,(H,24,25)(H,29,30);2,4-5,7,9,11-12H,3,6,8,10H2,1H3,(H,29,30)(H,23,24,25);2-3,8-10,12H,4-7,11H2,1H3,(H,29,30);2-4,9-10,12H,5-8,11H2,1H3,(H,29,30)/t2*11-,12+;2*12-/m0000/s1
InChIKeyVHOARAVZFMPQEU-GZCRWKFDSA-N
MW1701.68 g/mol
LogP8.36
Rot. Bonds14

About (2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrazin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrazin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrimidin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrimidin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid

(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrazin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrazin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrimidin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrimidin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid (PubChem CID 161300539) has the molecular formula C84H80F4N20O16 and a molecular weight of 1701.68 g/mol. Its IUPAC name is (2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrazin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrazin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrimidin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrimidin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid.

Molecular Properties

Compound Name(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrazin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrazin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrimidin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrimidin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
PubChem CID161300539
Molecular FormulaC84H80F4N20O16
Molecular Weight1701.68 g/mol
Exact Mass1700.60
IUPAC Name(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrazin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrazin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrimidin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrimidin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
SMILESC[C@H]1COc2c(N3CCN(c4cnccn4)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(c4ncccn4)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CC[C@@H](Nc4cnccn4)C3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CC[C@@H](Nc4ncccn4)C3)c(F)cc3c(=O)c(C(=O)O)cn1c23
InChIInChI=1S/4C21H20FN5O4/c1-11-10-31-20-17-13(19(28)14(21(29)30)9-27(11)17)6-15(22)18(20)26-5-2-12(8-26)25-16-7-23-3-4-24-16;1-11-10-31-19-16-13(18(28)14(20(29)30)9-27(11)16)7-15(22)17(19)26-6-3-12(8-26)25-21-23-4-2-5-24-21;1-12-11-31-20-17-13(19(28)14(21(29)30)10-27(12)17)8-15(22)18(20)26-6-4-25(5-7-26)16-9-23-2-3-24-16;1-12-11-31-19-16-13(18(28)14(20(29)30)10-27(12)16)9-15(22)17(19)25-5-7-26(8-6-25)21-23-3-2-4-24-21/h3-4,6-7,9,11-12H,2,5,8,10H2,1H3,(H,24,25)(H,29,30);2,4-5,7,9,11-12H,3,6,8,10H2,1H3,(H,29,30)(H,23,24,25);2-3,8-10,12H,4-7,11H2,1H3,(H,29,30);2-4,9-10,12H,5-8,11H2,1H3,(H,29,30)/t2*11-,12+;2*12-/m0000/s1
InChIKeyVHOARAVZFMPQEU-GZCRWKFDSA-N
XLogP8.36
TPSA420.74 Ų
H-Bond Donors6
H-Bond Acceptors32
Rotatable Bonds14
Heavy Atoms124
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001701.68
LogP ≤ 58.36
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1032

Analyze (2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrazin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrazin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrimidin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrimidin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrazin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrazin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrimidin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrimidin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid?
The IUPAC name of (2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrazin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrazin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrimidin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrimidin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid (CID 161300539) is (2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrazin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrazin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrimidin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrimidin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid.
What is the SMILES notation for (2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrazin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrazin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrimidin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrimidin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid?
The canonical SMILES for (2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrazin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrazin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrimidin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrimidin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid is C[C@H]1COc2c(N3CCN(c4cnccn4)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(c4ncccn4)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CC[C@@H](Nc4cnccn4)C3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CC[C@@H](Nc4ncccn4)C3)c(F)cc3c(=O)c(C(=O)O)cn1c23.
What is the InChIKey of (2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrazin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrazin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrimidin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrimidin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid?
The InChIKey is VHOARAVZFMPQEU-GZCRWKFDSA-N. The full InChI is InChI=1S/4C21H20FN5O4/c1-11-10-31-20-17-13(19(28)14(21(29)30)9-27(11)17)6-15(22)18(20)26-5-2-12(8-26)25-16-7-23-3-4-24-16;1-11-10-31-19-16-13(18(28)14(20(29)30)9-27(11)16)7-15(22)17(19)26-6-3-12(8-26)25-21-23-4-2-5-24-21;1-12-11-31-20-17-13(19(28)14(21(29)30)10-27(12)17)8-15(22)18(20)26-6-4-25(5-7-26)16-9-23-2-3-24-16;1-12-11-31-19-16-13(18(28)14(20(29)30)10-27(12)16)9-15(22)17(19)25-5-7-26(8-6-25)21-23-3-2-4-24-21/h3-4,6-7,9,11-12H,2,5,8,10H2,1H3,(H,24,25)(H,29,30);2,4-5,7,9,11-12H,3,6,8,10H2,1H3,(H,29,30)(H,23,24,25);2-3,8-10,12H,4-7,11H2,1H3,(H,29,30);2-4,9-10,12H,5-8,11H2,1H3,(H,29,30)/t2*11-,12+;2*12-/m0000/s1.
What are the key properties of (2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrazin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrazin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrimidin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrimidin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid?
(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrazin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrazin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrimidin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrimidin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid has a molecular weight of 1701.68 g/mol, XLogP of 8.36, 14 rotatable bonds, 6 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrazin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrazin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-[(3R)-3-(pyrimidin-2-ylamino)pyrrolidin-1-yl]-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;(2S)-7-fluoro-2-methyl-10-oxo-6-(4-pyrimidin-2-ylpiperazin-1-yl)-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid is sourced from PubChem (CID 161300539), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).